Connect Biopharma (CNTB) Financials: Revenue & Earnings

CNTB price $0.84 -0.00 -0.17%

Ticker
CNTB
Price
$0.84
Change
-0.00 -0.17%
Market cap ?
$52.97M
P/E ?
-0.96
Dividend yield ?
0.00%
Beta ?
-0.22
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
46
Value
59
Quality
30
Growth
50

Stocklytics score rationale: value 59, quality 30, growth 50.

Financials

2019202020212022202320242025
000002603300064000

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials…

Fair value

CNTB fair value Not meaningful. Price $0.84.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare CNTB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.27—114.86K
2026-08-12-0.27-0.312.75M743.31K
2026-05-12-0.34-0.2924.42K743.31K
2026-03-31-0.27-0.30—538
2025-11-12-0.04-0.03—4.91K
2025-08-13-0.03-0.2248.00K21.30K
2025-05-15-0.03-0.26—48.00K
2025-03-31-0.06-0.26260.10K20.90M
2024-09-050.02-0.033.32M2.95M
2024-04-16-0.08-0.03—2.92M
2023-12-12—-1.07—150.24M
2023-09-12-0.07-6.92——
2023-04-11-0.15-0.48——
2022-09-13-0.16-5.28——
2022-04-01-0.16-4.38——
2021-08-31-0.48-2.36——
2021-03-19-0.00———
2020-06-30-0.00———
2019-12-31-0.03———
2019-06-30-0.03———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-30Xanthopoulos Kleanthis GabrielBuy5.00K——
2026-09-30LIU JEAN IBuy8.98K——
2026-06-30Xanthopoulos Kleanthis GabrielBuy3.74K——
2026-06-30LIU JEAN IBuy6.72K——
2026-05-29Huang JamesBuy150.00K$2.48371.61K
2026-03-31Xanthopoulos Kleanthis GabrielBuy2.82K——
2026-03-31LIU JEAN IBuy5.06K——
2026-03-31Huang JamesBuy1.16M$3.454.00M
2026-03-18Huang JamesOther0——
2026-03-16Szekeres David LeslieOther0——
2026-03-16Szekeres David LeslieOther1.77M$1.773.14M
2026-03-16Szekeres David LeslieOther409.36K$0.97397.07K
2026-03-16Szekeres David LeslieOther400.00K$2.691.08M
2026-03-16Quart Barry DOther0——
2026-03-16Quart Barry DOther0——
2026-03-16Quart Barry DOther2.66M$1.774.71M
2026-03-16Quart Barry DOther432.39K$0.97419.42K
2026-03-16Quart Barry DOther700.00K$2.691.88M
2026-03-16Peraza LisaOther0——
2026-03-16Peraza LisaOther400.00K$1.15460.00K
2026-03-16Peraza LisaOther55.32K$0.9753.66K
2026-03-16Peraza LisaOther40.00K$1.1445.60K
2026-03-16Peraza LisaOther250.00K$2.69672.50K
2026-03-16Xanthopoulos Kleanthis GabrielOther0——
2026-03-16Xanthopoulos Kleanthis GabrielOther89.22K$8.16728.04K
2026-03-16Xanthopoulos Kleanthis GabrielOther21.27K$4.1287.63K
2026-03-16Xanthopoulos Kleanthis GabrielOther28.36K$1.2736.02K
2026-03-16Xanthopoulos Kleanthis GabrielOther33.54K$1.1839.58K
2026-03-16Xanthopoulos Kleanthis GabrielOther46.51K$1.0448.37K
2026-03-16Xanthopoulos Kleanthis GabrielOther60.00K$0.9657.60K
2026-03-16Xanthopoulos Kleanthis GabrielOther60.00K$2.50150.00K
2026-03-16WILSON KAREN JOther0——
2026-03-16WILSON KAREN JOther89.22K$8.16728.04K
2026-03-16WILSON KAREN JOther21.27K$4.1287.63K
2026-03-16WILSON KAREN JOther21.27K$1.2727.01K
2026-03-16WILSON KAREN JOther26.45K$1.1831.21K
2026-03-16WILSON KAREN JOther60.00K$0.9657.60K
2026-03-16WILSON KAREN JOther60.00K$2.50150.00K
2026-03-16Schoeneck James AOther120.00K$2.38285.60K
2026-03-16Schoeneck James AOther60.00K$2.50150.00K
2026-03-16LIU JEAN IOther34.00K$22.29757.86K
2026-03-16LIU JEAN IOther21.27K$4.1287.63K
2026-03-16LIU JEAN IOther21.27K$1.2727.01K
2026-03-16LIU JEAN IOther26.45K$1.1831.21K
2026-03-16LIU JEAN IOther60.00K$0.9657.60K
2026-03-16LIU JEAN IOther60.00K$2.50150.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 57, holders +11 vs prior quarter. Ownership 22.12%.

HolderSharesChangeChange %Value
IKARIAN CAPITAL, LLC4.54M4.39M+3038.68%10.80M
683 CAPITAL MANAGEMENT, LLC1.28M385.00K+42.78%3.06M
BOOTHBAY FUND MANAGEMENT, LLC973.73K936.73K+2531.71%2.32M
BLACKROCK, INC.871.65K871.65KNew2.07M
PERCEPTIVE ADVISORS LLC792.70K00.00%1.89M
ADAR1 CAPITAL MANAGEMENT, LLC700.00K-42.40K-5.71%1.67M
BML CAPITAL MANAGEMENT, LLC573.29K164.40K+40.21%1.36M
SILVERARC CAPITAL MANAGEMENT, LLC545.00K545.00KNew1.30M
RICHMOND BROTHERS, INC.535.61K59.03K+12.39%1.27M
KNOTT DAVID M JR444.86K57.03K+14.70%1.06M
STONEPINE CAPITAL MANAGEMENT, LLC364.25K54.25K+17.50%866.92K
MARSHALL WACE, LLP335.64K269.63K+408.45%798.83K
GEODE CAPITAL MANAGEMENT, LLC257.45K225.32K+701.31%612.74K
TWO SIGMA INVESTMENTS, LP199.38K151.92K+320.06%474.53K
DIADEMA PARTNERS LP196.99K-3.71K-1.85%468.82K
BURKEHILL GLOBAL MANAGEMENT, LP150.00K00.00%357.00K
VANGUARD PORTFOLIO MANAGEMENT LLC102.75K102.75KNew244.56K
SUSQUEHANNA INTERNATIONAL GROUP, LLP102.15K87.25K+585.56%243.11K
RENAISSANCE TECHNOLOGIES LLC87.30K-33.40K-27.67%207.77K
NORTHERN TRUST CORP82.86K82.86KNew197.21K
SIMPLEX TRADING, LLC81.95K81.95KNew195.04K
STATE STREET CORP66.70K66.70KNew158.75K
UBS GROUP AG66.45K66.42K+201266.67%158.15K
PERSISTENT ASSET PARTNERS LTD49.87K-874-1.72%118.70K
KOA WEALTH MANAGEMENT, LLC49.60K00.00%118.05K

Earnings and financials

Connect Biopharma Holdings Limited (CNTB) trades at $0.84, with a market cap of $52.97M and a trailing P/E of -0.96. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
000002603300064000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Connect Biopharma (CNTB) Financials: Revenue & Earnings

CNTB$0.84-0.00 -0.17%

$52.97M

Market Cap

-0.96

P/E

—

Forward P/E

46

Score

Price History